Mumbai, March 3: Sweden's AstraZeneca Pharmaceuticals AB has made a delisting offer to shareholders of its Indian subsidiary AstraZeneca Pharma India Ltd. AstraZeneca Pharma India today announced that its board of directors would meet on March 5 to ... Calcutta Telegraph, 1 week ago
Sales decline 69.90% to Rs 45.27 crore Net loss of Fresenius Kabi Oncology reported to Rs 63.63 crore in the quarter ended December 2013 as against net profit of Rs 48.36 crore during the previous quarter ended December 2012. Sales declined 69.90% to Rs 45.27 ...Business Standard, 1 month ago Fresenius Kabi Oncology: Updates on delisting offer Money Control, 2 months ago Fresenius Kabi Oncology: Resignation of director Money Control, 2 months ago
01/06/2014 | 03:26pm US/Eastern Recommend: 0 Contract awarded for tender for supply of anti cancer drugs Contract value: INR 9,95,99,108 Contract Date: 06-Jan-2014 Contractor name : FRESENIUS KABI ONCOLOGY LIMITED country : India ...4 Traders, 2 months ago
Data Integrity in a Nutshell: Industry must take bold steps to assure the data used for drug quality decisions is trustworthy
Regulatory inspectors have started digging much deeper into data, no longer accepting batch release data and supportive testing at face value. Even worse, this effort is justified: they have cited a number of firms for violations of data ...Scientific Computing, 2 months ago
on your WebpageAdd Widget >Get your members hooked!